Global Health CEO, MD, chairman, board of directors and AGM

Mutual fund votes, meeting of 19 Sep 2025, 27 fund houses

• To consider and adopt the Standalone Financial Statements of the Company for the financial year ended March 31, 2025, the Consolidated Financial Statements for the financial year ended March 31, 2025 and the Reports of the Board of Directors and Auditors thereon.MoreLess

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund

  • Angel One Mutual FundNon-disclosure of financial statements of subsidiaries on the website of the Company.
  • Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundUnqualified financial statements (except certain non-material remarks identified in CARO report). Non-Compliant with Companies Act, 2013 and Regulation 46(2)(s) of SEBI LODR: Non-disclosure of financial statements of subsidiaries on the website of the Company.

  22 for5 against
• To declare final dividend of Rs. 0.50/- per Equity Share for the financial year ended March 31, 2025.

  27 for0 against
• To appoint a Director in place of Mr. Ravi Kant Jaipuria (DIN-00003668) who retires by rotation and being eligible, offers himself for re-election.

  ›Against HSBC Mutual Fund, Invesco Mutual Fund, Jio BlackRock Mutual Fund, Mirae Asset Mutual Fund, SBI Mutual Fund

  • HSBC Mutual FundA vote AGAINST the following nominees is warranted because:• Ravi Kant Jaipuria has failed to attend at least 75 percent of board and committee meetings in the most recent fiscal year, without a satisfactory explanation.
  • Invesco Mutual FundRavi Jaipuria, 70, is the promoter and Chairperson of RJ Corp. He serves as the Chairperson of Varun Beverages Limited and Devyani International Ltd. He has been on the board of Global Health Ltd. since October 2015. RJ Corp Limited held 6.6% equity in the company as on 30 June 2025. He retires by rotation and his reappointment is in line with statutory requirements. However, we raise concern that he attended only four out of seven (57%) board meetings held in FY25 and 18 out of 28 (64%) board meetings held in the past three years. We expect directors to attend all board meetings and we have a threshold of 75% attendance over a three-year period. Given his low board meeting attendance, we are unable to support his reappointment. We do not support the resolution
  • Jio BlackRock Mutual Fund, SBI Mutual FundRavi Jaipuria, 70, is the promoter and Chairperson of RJ Corp. He serves as the Chairperson of Varun Beverages Limited and Devyani International Ltd. He has been on the board of Global Health Ltd. since October 2015. RJ Corp Limited held 6.6% equity in the company as on 30 June 2025. He retires by rotation and his reappointment is in line with statutory requirements. However, we raise concern that he attended only four out of seven (57%) board meetings held in FY25 and 18 out of 28 (64%) board meetings held in the past three years. We expect directors to attend all board meetings and we have a threshold of 75% attendance over a three-year period. Given his low board meeting attendance, we are unable to support his reappointment. We do not support the resolution.
  • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)

  22 for5 against
• Re-appointment of Mr. Vikram Singh Mehta as an Independent Director of the Company

  27 for0 against
• Re-appointment of Mr. Hari Shanker Bhartia as an Independent Director of the Company.

  27 for0 against
• Approval of remuneration payable to Cost Auditors

  27 for0 against
• Appointment of M/s MAKS & CO., Company Secretaries in Practice, as Secretarial Auditors of the Company

  27 for0 against
• Re-appointment of Dr. Naresh Trehan as Chairman and Managing Director (CMD) of the Company.

  ›Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, LIC Mutual Fund, Navi Mutual Fund, Zerodha Mutual Fund

  • Angel One Mutual FundGovernance concern: Combined position of Chairman and Managing Director may lead to concentration of powers in the hands of single person.
  • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Navi Mutual Fund, Zerodha Mutual FundCompliant with law. No concern with regard to the profile, time commitments, attendance performance of the Director and continuation over 79 years of age. Past remuneration payments appear fair and reasonable when compared with the Company performance and Peer remuneration. No major concern on the remuneration terms proposed; although disclosure on variable component and performance parameters could be improved. Also, remuneration payments, although stated to be linked to performance parameters, however, the same is also fixed at last drawn salary being the lower threshold. Yet, no major concern is identified presently as the overall quantum appears reasonable considering the Company size and performance. Governance concern: Combined position of Chairman and Managing Director.
  • LIC Mutual FundConcerns over disclosure on variable component and performance parameters could be improved. Also, remuneration payments, although stated to be linked to performance parameters, however, the same is also fixed at last drawn salary being the lower threshold. Yet, no major concern is identified presently as the overall quantum appears reasonable considering the Company size and performance. Governance concern: Combined position of Chairman and Managing Director.

  20 for7 against
• Re-appointment of Dr. Naresh Trehan as Chairman of Heart Institute & Chief Cardiac Surgeon (CCS)

  ›Against Invesco Mutual Fund, Jio BlackRock Mutual Fund, Mirae Asset Mutual Fund

  • Invesco Mutual FundDr. Naresh Trehan, 79, is the promoter, Chairperson, and Managing Director (CMD) of Global Health Ltd. He also serves as Chairperson of the Heart Institute and as the Chief Cardiac Surgeon (CCS). We raise concern over his membership of the Nomination and Remuneration Committee (NRC). We believe the NRC must only comprise Independent Directors to avoid any potential conflict of interest. His FY25 pay aggregated Rs. 260.9 mn, including Rs. 62.5 mn as CMD and Rs. 198.4 mn as CCS. For FY26, his proposed pay is Rs. 298.3 mn, including Rs. 72.0 mn as CMD and Rs. 226.3 mn as CCS. Shareholder approval is sought for his appointment and remuneration as CCS. While we support his appointment as CCS, we are unable to support his remuneration as CCS. On an aggregate basis, the compensation is high when compared to peers. His maximum pay as CCS can go up to Rs. 370.0 mn by FY31. The linkage of his compensation to the cardiac segment revenue and surgeries is not clearly articulated, making it difficult to assess whether the proposed structure ties his compensation to performance and outcomes. In the absence of clarity, we do not support the resolution
  • Jio BlackRock Mutual FundDr. Naresh Trehan, 79, is the promoter, Chairperson, and Managing Director (CMD) of Global Health Ltd. He also serves as Chairperson of the Heart Institute and as the Chief Cardiac Surgeon (CCS).We raise concern over his membership of the Nomination and Remuneration Committee (NRC). We believe the NRC must only comprise Independent Directors to avoid any potential conflict of interest.His FY25 pay aggregated Rs. 260.9 mn, including Rs. 62.5 mn as CMD and Rs. 198.4 mn as CCS. For FY26, his proposed pay is Rs. 298.3 mn, including Rs. 72.0 mn as CMD and Rs. 226.3 mn as CCS.Under resolution #9, shareholder approval is sought for his appointment and remuneration as CCS. While we support his appointment as CCS, we are unable to support his remuneration as CCS. On an aggregate basis, the compensation is high when compared to peers. His maximum pay as CCS can go up to Rs. 370.0 mn by FY31. The linkage of his compensation to the cardiac segment revenue and surgeries is not clearly articulated, making it difficult to assess whether the proposed structure ties his compensation to performance and outcomes. In the absence of clarity, we do not support the resolution.
  • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)

  24 for3 against

Mutual fund votes, meeting of 15 Mar 2025, 22 fund houses

• Reappointment of Ms. Praveen Mahajan (DIN: 07138514) as Non- Executive Independent Director of the Company for a second term of 5 years

  22 for0 against

Mutual fund votes, meeting of 27 Dec 2024, 22 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

• Approval of winding up of the existing Global Health Limited - Employee Stock Option Plan 2021 of the Company

  ›Against Kotak Mahindra Mutual Fund

  • Kotak Mahindra Mutual FundThe company has stated that the Exercise Price shall be such as decided by the NRC as on date of Grant. As part of the Schedule I Part C of SEBI SBEB & SE Regulations, the total number of options granted along with the exercise price and the pricing formula should be mentioned. Given that the company has not provided the same and the exercise price would be determined as per Board/NRC discretion, we do not support the resolution.

  21 for1 against
• Approval of the Global Health Limited (GHL) Employees Long Term Share Based Incentive Plan -2024 consisting of Part A-GHL Employees Stock Option Scheme, 2024 and Part B-GHL Employees Stock Purchase Scheme, 2024 (“collectively referred as GHL LTIP 2024 Plan”) and its implementation through Trust (as may be required)MoreLess

  ›Against Axis Mutual Fund, Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, SBI Mutual Fund, Tata Mutual Fund, Zerodha Mutual Fund

  • Axis Mutual Fund, Invesco Mutual Fund, Navi Mutual FundGHL LTIP 2024 plan will be implemented through the trust route by way of fresh issue/ secondary acquisition/ both. GHL LTIP 2024 Plan consists of ESOS 2024 (stock option scheme) and ESPS 2024 (stock purchase scheme). The maximum dilution due to fresh issue will be 0.6% on the expanded capital base. There is lack of clarity on the exercise price under GHL LTIP 2024 Plan. The plan states that the exercise price will be determined by the Nomination and Remuneration Committee (NRC) and will not be below the face value. If the options/ shares are offered at the current face value (Rs. 2.0), the exercise price will be at a discount of ~99.8% to the current market price. Stock options are ‘pay at risk’ options that employees accept at the time of grant. In the case of deeply discounted options/ share purchase schemes, there is no alignment between the interests of investors and those of employees. We make an exception in the case of stock option schemes where the vesting is mandatorily linked to pre-defined performance parameters and the company has disclosed the targets for such parameters. In the current case, the vesting is primarily linked to continued employment. Further, we do not support discounted grants under employee stock purchase schemes. We do not support the resolution.
  • Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundNon-Compliant with SEBI SBEB & SE Regulations: No specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Governance & Transparency Concern: Estimate on potential benefits to a single employee appears to be excessive.
  • HDFC Mutual FundThere is lack of clarity on the exercise price of ESOPs. In the case of deeply discounted options, there is no alignment between the interests of investors and those of employees.
  • Kotak Mahindra Mutual FundNo specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Moreover, estimate on potential benefits to a single employee appears to be excessive. Hence voting against.
  • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)
  • Motilal Oswal Mutual FundNon-Compliant with law and regulations.
  • Nippon India Mutual FundEstimate on potential benefits to a single employee appears to be excessive.
  • SBI Mutual FundGHL LTIP 2024 plan will be implemented through the trust route by way of fresh issue/ secondary acquisition/ both. GHL LTIP 2024 Plan consists of ESOS 2024 (stock option scheme) and ESPS 2024 (stock purchase scheme). The maximum dilution due to fresh issue will be 0.6% on the expanded capital base. There is lack of clarity on the exercise price under GHL LTIP 2024 Plan. The plan states that the exercise price will be determined by the Nomination and Remuneration Committee (NRC) and will not be below the face value. If the options/ shares are offered at the current face value (Rs. 2.0), the exercise price will be at a discount of ~99.8% to the current market price. We do not support the resolution.
  • Tata Mutual FundThere is lack of clarity on the exercise price under GHL LTIP 2024 Plan. The plan states that the exercise price will be determined by the Nomination and Remuneration Committee (NRC) and will not be below the face value. If the options/ shares are offered at the current face value (Rs. 2.0), the exercise price will be at a discount of ~99.8% to the current market price. Stock options are ‘pay at risk’ options that employees accept at the time of grant. In the case of deeply discounted options/ share purchase schemes, there is no alignment between the interests of investors and those of employees. We make an exception in the case of stock option schemes where the vesting is mandatorily linked to pre-defined performance parameters and the company has disclosed the targets for such parameters. In the current case, the vesting is primarily linked to continued employment. We do not support the resolution.

  6 for16 against
• Grant of options and / or shares of the Company to the employees of the Subsidiary/Associate Company(ies) under the GHL LTIP 2024 Plan

  ›Against Axis Mutual Fund, Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Tata Mutual Fund, Zerodha Mutual Fund

  • Axis Mutual FundThrough resolution #3, the company seeks shareholder approval to extend the benefits of GHL LTIP 2024 Plan to employees of subsidiary and associate companies. Our view is linked to resolution #2. Further, we do not support extension of stock option/ stock purchase schemes to associate companies (present/ future). We do not support the resolution.
  • Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundNon-Compliant with SEBI SBEB & SE Regulations: No specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Governance & Transparency Concern: Estimate on potential benefits to a single employee appears to be excessive. Lack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. Benefits to be extended to Group Companies other than Subsidiary Companies without compelling justification or cost reimbursement provision.
  • HDFC Mutual FundThere is lack of clarity on the exercise price of ESOPs. In the case of deeply discounted options, there is no alignment between the interests of investors and those of employees.
  • Invesco Mutual FundThe company seeks shareholder approval to extend the benefits of GHL LTIP 2024 Plan to employees of subsidiary and associate companies. Further, we do not support extension of stock option/ stock purchase schemes to associate companies (present/ future). We do not support the resolution
  • Kotak Mahindra Mutual FundLack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. While we support the extension of stock options to employees of subsidiaries, we do not support these to be extended to employees of group companies, associate companies and/or holding company. Hence voting against.
  • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)
  • Motilal Oswal Mutual FundNon-Compliant with law and regulations.
  • Nippon India Mutual FundLack of clarity
  • Tata Mutual FundGHL LTIP 2024 Plan to employees of subsidiary and associate companies. Our view is linked to resolution #2. Further, we do not support extension of stock option/ stock purchase schemes to associate companies (present/ future). We do not support the resolution.

  5 for14 against
• Authorization for set up of trust to subscribe to new shares of GHL and / purchase of existing shares of GHL from open market for the implementation of GHL LTIP 2024 Plan

  ›Against Axis Mutual Fund, Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Tata Mutual Fund, Zerodha Mutual Fund

  • Axis Mutual FundThrough resolution #4, the company seeks shareholder approval for setting up a trust for implementation of GHL LTIP 2024 Plan. The trust will be authorised to subscribe, acquire, purchase, hold and deal in the equity shares of the company for implementation of GHL LTIP 2024 Plan. Our view is linked to resolution #2. We do not support the resolution.
  • Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundNon-Compliant with SEBI SBEB & SE Regulations: No specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Governance& Transparency Concern: Estimate on potential benefits to a single employee appears to be excessive. Lack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. Benefits to be extended to Group Companies other than Subsidiary Companies without compelling justification or cost reimbursement provision. SES has concerns in relation to the fact that the trust will work for scheme implementation towards, and will use financial assistance in favour of group company employees other than subsidiary companies.
  • HDFC Mutual FundThere is lack of clarity on the exercise price of ESOPs. In the case of deeply discounted options, there is no alignment between the interests of investors and those of employees.
  • Invesco Mutual FundThe company seeks shareholder approval for setting up a trust for implementation of GHL LTIP 2024 Plan. The trust will be authorised to subscribe, acquire, purchase, hold and deal in the equity shares of the company for implementation of GHL LTIP 2024 Plan. We do not support the resolution
  • Kotak Mahindra Mutual FundNo specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Lack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. While we support the extension of stock options to employees of subsidiaries, we do not support these to be extended to employees of group companies, associate companies and/or holding company. Hence voting against.
  • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)
  • Motilal Oswal Mutual FundNon-Compliant with law and regulations.
  • Nippon India Mutual FundInadequate Disclosure
  • Tata Mutual FundInter-linked with resolution no. 2 & 3; trust will work for scheme implementation towards, and use financial assistance in favour of group company employees other than subsidiary companies.

  5 for14 against
• Financial assistance by the Company to the Trust/ Trustees for subscription of new shares of GHL and / purchase of existing shares of GHL from open market under GHL LTIP 2024 Plan

  ›Against Axis Mutual Fund, Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Tata Mutual Fund, Zerodha Mutual Fund

  • Axis Mutual FundThrough resolution #5, the company seeks shareholder approval for providing financial assistance to the trust/ trustees for purchasing shares for implementation of GHL LTIP 2024 Plan. The financial assistance will not exceed 5% of the aggregate of the paid-up share capital and free reserves. Our view is linked to resolution #2. We do not support the resolution.
  • Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundNon-Compliant with SEBI SBEB & SE Regulations: No specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Governance& Transparency Concern: Estimate on potential benefits to a single employee appears to be excessive. Lack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. Benefits to be extended to Group Companies other than Subsidiary Companies without compelling justification or cost reimbursement provision. SES has concerns in relation to the fact that the trust will work for scheme implementation towards, and will use financial assistance in favour of group company employees other than subsidiary companies.
  • HDFC Mutual FundThere is lack of clarity on the exercise price of ESOPs. In the case of deeply discounted options, there is no alignment between the interests of investors and those of employees.
  • Invesco Mutual FundThrough this resolution , the company seeks shareholder approval for providing financial assistance to the trust/ trustees for purchasing shares for implementation of GHL LTIP 2024 Plan. The financial assistance will not exceed 5% of the aggregate of the paid-up share capital and free reserves. We do not support the resolution.
  • Kotak Mahindra Mutual FundNo specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Lack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. While we support the extension of stock options to employees of subsidiaries, we do not support these to be extended to employees of group companies, associate companies and/or holding company. Hence voting against.
  • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)
  • Motilal Oswal Mutual FundNon-Compliant with law and regulations.
  • Nippon India Mutual FundInadequate Disclosure
  • Tata Mutual FundInter-linked with resolution no. 2 & 3; trust will work for scheme implementation towards, and use financial assistance in favour of group company employees other than subsidiary companies.

  5 for14 against
• Financial assistance by the Company to the employees for subscription of new shares of GHL and / purchase of existing shares of GHL from open market under GHL LTIP 2024 Plan

  ›Against Axis Mutual Fund, Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Tata Mutual Fund, Zerodha Mutual Fund

  • Axis Mutual FundThrough resolution #6, the company seeks shareholder approval for providing financial assistance to the employees for purchasing shares under GHL LTIP 2024 Plan. Our view is linked to resolution #2. We do not support the resolution.
  • Bandhan Mutual Fund, Baroda BNP Paribas Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual FundNon-Compliant with SEBI SBEB & SE Regulations: No specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Governance & Transparency Concern: Estimate on potential benefits to a single employee appears to be excessive. Lack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. Benefits to be extended to Group Companies other than Subsidiary Companies without compelling justification or cost reimbursement provision. SES has concerns in case the financial assistance may be given in favour of group company employees other than subsidiary companies without consideration.
  • HDFC Mutual FundThere is lack of clarity on the exercise price of ESOPs. In the case of deeply discounted options, there is no alignment between the interests of investors and those of employees.
  • Invesco Mutual FundThe company seeks shareholder approval for providing financial assistance to the employees for purchasing shares under GHL LTIP 2024 Plan. We do not support the resolution
  • Kotak Mahindra Mutual FundNo specific disclosure on exercise price under the Plan and no specific disclosure on exercise period under Part B of the Plan which relates to Employee Stock Purchase Scheme. Lack of clarity regarding whether the Scheme is for the benefit of employees of only subsidiary and associate companies or whether it includes other group companies as well. While we support the extension of stock options to employees of subsidiaries, we do not support these to be extended to employees of group companies, associate companies and/or holding company. Hence voting against.
  • Mirae Asset Mutual FundAs per advisory recommendation (passive holding)
  • Motilal Oswal Mutual FundNon-Compliant with law and regulations.
  • Nippon India Mutual FundBenefits to be extended to Assciate/ Group Companies other than Subsidiary Companies without justification or cost reimbursement provision.
  • Tata Mutual FundInter-linked with resolution no. 2 & 3; financial assistance may be given in favour of group company employees other than subsidiary companies without consideration

  5 for14 against

Mutual fund votes, meeting of 19 Sep 2024, 21 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

• To consider and adopt the Standalone Financial Statements of the Company for the financial year ended March 31, 2024, the Consolidated Financial Statements for the financial year ended March 31, 2024 and the Reports of the Board of Directors and Auditors thereon.MoreLess

  21 for0 against
• To appoint a Director in place of Mr. Sunil Sachdeva (DIN-00012115) who retires by rotation and being eligible, offers himself for re-election.

  ›Against Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, PGIM India Mutual Fund

  • Bajaj Finserv Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, PGIM India Mutual FundCompliant with law. Governance Concern: The director holds 2 Full- time positions in unrelated entities.

  17 for4 against
• To approve remuneration of M/s. Ramanath Iyer & Co., Cost Auditorsnof the Company for Financial Year 2024-25n

  21 for0 against
• To approve the limit under Section 180 (1)(a) of the Companies Act,n2013 for creation of charge/pledge.

  19 for0 against

Mutual fund votes, meeting of 3 Aug 2024, 20 fund houses

• To approve the Scheme of Amalgamation between Medanta Holdings Private Limited and Global Health Limited and their respective shareholders and creditors.

  ›Against Invesco Mutual Fund

  • Invesco Mutual FundAs per the notice, the independent directors shall be paid commission of Rs. 2.0 mn each in FY24. However, in the subsequent years, the Nomination & Remuneration Committee will determine the actual commission payable, ensuring it does not exceed 1% of the company’s net profit. The company has not capped the commission payable and has not defined a tenure for payment of commission, the resolution is effectively valid in perpetuity. We do not support resolutions in perpetuity: shareholders must get a chance to periodically review such payments

  19 for1 against

Mutual fund votes, meeting of 26 Jun 2024, 21 fund houses

• Payment of Commission to Independent Directors

  ›Against Axis Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HSBC Mutual Fund, ICICI Prudential Mutual Fund, Invesco Mutual Fund, JM Financial Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Trust Mutual Fund

  • Axis Mutual FundAs per the notice, the independent directors shall be paid commission of Rs. 2.0 mn each in FY24. However, in the subsequent years, the Nomination & Remuneration Committee will determine the actual commission payable, ensuring it does not exceed 1% of the company’s net profit. The company has not capped the commission payable and has not defined a tenure for payment of commission, the resolution is effectively valid in perpetuity. We do not support resolutions in perpetuity: shareholders must get a chance to periodically review such payments.
  • Bandhan Mutual Fund, Groww Mutual Fund, JM Financial Mutual Fund, PGIM India Mutual Fund, Trust Mutual FundCompliant with the law. Governance Concern: Perpetual approval.
  • Edelweiss Mutual FundThe sharing amounnt is too highh for independent directors and reduces PAT of minority share holdes.
  • HSBC Mutual FundA vote AGAINST this resolution is warranted as the approval will be valid till perpetuity and shareholders will not get to review the payments in the future.
  • ICICI Prudential Mutual FundThe independent directors shall be paid commission of Rs. 2.0 million each in FY2024. However, in the subsequent years, the Nomination & Remuneration Committee will determine the actual commission payable. The company has not capped the commission payable and has not defined a tenure for payment of commission. The validity of the resolution may be in perpetuity. Hence, the AMC voted against the resolution.
  • Invesco Mutual FundAs per the notice, the independent directors shall be paid commission of Rs. 2.0 mn each in FY24. However, in the subsequent years, the Nomination & Remuneration Committee will determine the actual commission payable, ensuring it does not exceed 1% of the company’s net profit. The company has not capped the commission payable and has not defined a tenure for payment of commission, the resolution is effectively valid in perpetuity. We do not support resolutions in perpetuity: shareholders must get a chance to periodically review such payments
  • Nippon India Mutual FundPerpetual Approval

  10 for11 against